PROGESTERONE RECEPTOR AND BREAST CANCER
PROGESTERONE RECEPTOR AND BREAST CANCER
批准号:
6709736
负责人:
JOHN P LYDON
金额:
$1.52万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2004-03-31
关键词:
RNase protection assay apoptosis breast neoplasms carcinogenesis cell proliferation cyclins disease /disorder model epidermal growth factor gene targeting genetic strain genetically modified animals genotype histogenesis histopathology homologous transplantation hormone related neoplasm /cancer immunocytochemistry laboratory mouse mammary epithelium mammary gland neoplasm /cancer transplantation phenotype progesterone receptors
中文摘要
乳腺癌被认为是女性中最常见的恶性肿瘤
在北美,目前估计终身风险为1/
八 最重要的是,生殖史,或者更具体地说,
类固醇激素状态已被证明是一个重要的风险因素。
最近,我产生了一个孕激素受体(PR)敲除(PRKO)小鼠,
已经证明孕酮(P)及其受体PR,
是正常乳腺增生所必需的,
分化 P在乳腺肿瘤发生中的作用已被证实,
这是一个多年来一直存在争议的问题,主要是因为P可以
预防或抑制乳腺肿瘤发生。 为了澄清复杂的
P与乳腺肿瘤发生的时间关系
小鼠将被用来确定是否P诱导增殖
信号在乳腺癌中的作用,
消除PR功能对乳腺肿瘤进展的影响。
这项建议的具体目的是:1)评估是否
PR功能改变小鼠对致癌物诱导的
乳腺肿瘤发生的形态学、组织学和分子生物学研究
2)确定公关职能是否在发展中发挥作用
Grunder小鼠表现出的激素依赖性乳腺肿瘤,
定义公关是否参与了这些进展
将肿瘤转化为激素非依赖性表型;以及3)定义不同的
乳腺上皮和间质来源的PR群体对
利用相互乳腺进行乳腺发育和肿瘤发生
移植技术 除了推进我们目前的
了解P对乳腺肿瘤发生的作用,信息
这些研究将有助于设计有效的战略,
乳腺癌的预防和治疗以及促进
重新评价目前使用孕激素避孕的情况,
绝经后激素替代疗法
英文摘要
Breast cancer is recognized as the most prevalent malignancy among women
in North America with a life time risk currently estimated to be one in
eight. Most importantly, reproductive history or more specifically
steroid hormonal status has been shown to be an important risk factor.
Recently, I generated a progesterone receptor (PR) knockout (PRKO) mouse
that has demonstrated that progesterone (P), and its receptor, the PR,
are absolutely required for normal mammary gland proliferation and
differentiation. The involvement of P in mammary tumorigenesis has been
a matter of controversy for several years mainly because P can
protentiate or inhibit mammary tumorigenesis. To clarify the complex
temporal relationship between P and mammary tumorigenesis, the PRKO
mouse will be utilized to determine whether the P indued-proliferative
signal has a role to play in breast cancer by investigating the effects
of removing PR function on mammary tumor progression.
The specific aims of this proposal are to: 1) evaluate whether removal
of PR function alters murine susceptibility to carcinogen-induced
mammary tumorigenesis at the morphological, histological, and molecular
level; 2) determine whether PR function has a role in the development
of hormone dependent mammary tumors exhibited by the Grunder mouse and
define whether the PR has an involvement in the progression of these
tumors to a hormone independent phenotype; and 3) to define the distinct
effects of mammary epithelial and stromal derived PR populations on
mammary development and tumorigenesis by using reciprocal mammary gland
transplantation technology. Apart from advancing our current
understanding of P's contribution to mammary tumorigenesis, information
from these studies will aid in the design of effective strategies for
breast cancer prevention and treatment as well as prompting a
reevaluation of the current use of progestins in contraception and
postmenopausal hormonal replacement therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Analysis of Uterine Receptivity
-
批准号:9300931
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:9813937
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:10453621
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:8898860
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:9105423
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:10217213
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
Molecular Analysis of Uterine Receptivity
-
批准号:10663198
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2002
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6513371
-
项目类别:
-
资助金额:$10.97万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:6965687
-
项目类别:
-
资助金额:$31.88万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:2597595
-
项目类别:
-
资助金额:$10.47万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6376709
-
项目类别:
-
资助金额:$11.06万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6173001
-
项目类别:
-
资助金额:$10.93万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:7229070
-
项目类别:
-
资助金额:$30.22万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:7394451
-
项目类别:
-
资助金额:$30.22万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
-
批准号:7065681
-
项目类别:
-
资助金额:$31.13万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:6896034
-
项目类别:
-
资助金额:$5.27万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
PROGESTERONE RECEPTOR AND BREAST CANCER
-
批准号:2896440
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1998
-
负责人:JOHN P LYDON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: